Agarose Bead Technologies (ABT) has expanded its facility in Burgos, Spain, about 250 km north of Madrid. In addition to the four existing cleanrooms, this 1000 square-meters expansion includes two ...

Articles In Color Color reprints are printed on 70# enamel paper and can be reproduced in color or in black and white. Color articles reprinted in black and white will be charged black and white ...

This website (the “Site”) is operated by Informa Connect, a trading division of the Informa Group. The parent company of the Informa Group is Informa PLC. Informa Connect (“Informa Connect”, “we” or ...

With this issue, we bid a reluctant farewell to our managing editor as she retires. Cheryl and I have known her and appreciated her friendship for 26 years. Her accumulated knowledge of cell and gene ...

In a Series A financing round led by founding investor Versant Ventures, obesity drug developer SixPeaks has secured $30 million in funding. Beyond this, Anglo-Swedish pharma giant AstraZeneca will ...

The buildout of its $1.5 billion facility will establish the Anglo-Swedish drugmaker’s first manufacturing presence in Singapore. Additionally, it will be AstraZeneca’s first ADC plant to produce the ...

Sanofi will build a €1 billion ($1.1 billion) mAb production facility in Vitry-sur-Seine, while it invests €100 million to bolster capacity at its Le Trait site in Normandy and invests €10 million at ...

In 2021, Fujifilm began constructing a biomanufacturing site in Holly Springs, North Carolina at a cost of ¥200 billion (then $2 billion, now $1.3 billion) for its contract development manufacturing ...

Streamlining process development has been the focus of the biotechnology industry over the past several years. To be financially viable in the current market, a company has to be competitive in all ...

Founded in the middle of 2002, BPI published its first issue in January of 2003. Our 20th-anniversary issue thus takes the form of a state-of-the-early-21st-century industry report. Assembling this ...

Protein A has made monoclonal antibodies (MAbs) highly manufacturable and easier to develop in laboratories. Its use has enabled purification platform approaches, which have been key elements in ...

The “happy new year” routines are pretty much over with by now, with their many variations on “shhh, don’t scare the new year away” and “2023 has got to be an improvement” among other expressions of ...